TROG Cancer Research
Members Login   CQMS Login

Non-TROG trials

NOX66-002A  - this trial is to determine the efficiency and safety of a new medication (NOX66) as combination radiotherapy treatment for prostate cancer patients. 

Primary sponsor: Noxopharm
Contract Research Organisation: TROG

We are thankful to our 14,500 patients who have participated in our research. Please continue the generous support.